Free tool
FAERS Monitor: Sodium Bicarbonate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 220790 or its brand name (Sodium Bicarbonate, Sodium Bicarbonate). Reports on generic versions are filed under their own applications.
Reports
23,575
Serious
20,176
86% of reports
Hospitalization
12,341
Death reported
4,325
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- acute kidney injury1,735
- off label use1,699
- drug ineffective1,662
- diarrhoea1,477
- renal failure1,400
- nausea1,209
- anaemia1,137
- death1,076
- dyspnoea1,054
- pain996
- pneumonia993
- pyrexia985
- fatigue971
- vomiting960
- chronic kidney disease875
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 108 |
| 2005 | 144 |
| 2006 | 172 |
| 2007 | 188 |
| 2008 | 230 |
| 2009 | 209 |
| 2010 | 364 |
| 2011 | 703 |
| 2012 | 624 |
| 2013 | 575 |
| 2014 | 831 |
| 2015 | 928 |
| 2016 | 1,330 |
| 2017 | 1,700 |
| 2018 | 1,457 |
| 2019 | 1,522 |
| 2020 | 1,615 |
| 2021 | 1,864 |
| 2022 | 1,940 |
| 2023 | 1,823 |
| 2024 | 1,908 |
| 2025 | 1,948 |
| 2026 | 1,390 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,584 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| chronic kidney diseaseSignal | 875 | 10.4 | 9.7 | 7,351 |
| acute kidney injurySignal | 1,735 | 10.2 | 9.8 | 14,362 |
| renal failureSignal | 1,400 | 9.5 | 9.0 | 10,587 |
| anaemiaSignal | 1,137 | 5.3 | 5.0 | 4,024 |
| pneumoniaSignal | 993 | 2.7 | 2.6 | 1,111 |
| pyrexiaSignal | 985 | 2.5 | 2.4 | 934 |
| diarrhoeaSignal | 1,477 | 2.0 | 1.9 | 809 |
| vomiting | 960 | 1.8 | 1.7 | 363 |
| off label use | 1,699 | 1.7 | 1.7 | 547 |
| dyspnoea | 1,054 | 1.7 | 1.6 | 285 |
| pain | 996 | 1.4 | 1.4 | 141 |
| nausea | 1,209 | 1.4 | 1.3 | 121 |
| drug ineffective | 1,662 | 1.1 | 1.1 | 25 |
| death | 1,076 | 1.1 | 1.1 | 13 |
| fatigue | 971 | 1.1 | 1.0 | 11 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.